Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress

BackgroundLiver cancer is one of the most malignant human cancers, with few treatments and a poor prognosis. Erianin (ERN) is a natural compound with multiple pharmacological activities that has been reported to have numerous excellent effects against liver cancer in experimental systems. However, i...

Full description

Bibliographic Details
Main Authors: Anhui Yang, Zhen Sun, Rui Liu, Xin Liu, Yue Zhang, Yulin Zhou, Ye Qiu, Xinrui Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.727605/full
_version_ 1818692473316179968
author Anhui Yang
Zhen Sun
Rui Liu
Xin Liu
Yue Zhang
Yulin Zhou
Ye Qiu
Xinrui Zhang
Xinrui Zhang
author_facet Anhui Yang
Zhen Sun
Rui Liu
Xin Liu
Yue Zhang
Yulin Zhou
Ye Qiu
Xinrui Zhang
Xinrui Zhang
author_sort Anhui Yang
collection DOAJ
description BackgroundLiver cancer is one of the most malignant human cancers, with few treatments and a poor prognosis. Erianin (ERN) is a natural compound with multiple pharmacological activities that has been reported to have numerous excellent effects against liver cancer in experimental systems. However, its application in vivo has been limited due to its poor aqueous solubility and numerous off-target effects. This study aimed to improve the therapeutic efficacy of ERN by developing novel ERN-loaded tumor-targeting nanoparticles.ResultsIn this study, ERN was loaded into liposomes by ethanol injection (LP-ERN), and the resulting LP-ERN nanoparticles were treated with transferrin to form Tf-LP-ERN to improve the solubility and enhance the tumor-targeting of ERN. LP-ERN and Tf-LP-ERN nanoparticles had smooth surfaces and a uniform particle size, with particle diameters of 62.60 nm and 88.63 nm, respectively. In HepG2 and SMMC-7721 cells, Tf-LP-ERN induced apoptosis, decreased mitochondrial membrane potentials and increased ERN uptake more effectively than free ERN and LP-ERN. In xenotransplanted mice, Tf-LP-ERN inhibited tumor growth, but had a minimal effect on body weight and organ morphology. In addition, Tf-LP-ERN nanoparticles targeted tumors more effectively than free ERN and LP-ERN nanoparticles, and in tumor tissues Tf-LP-ERN nanoparticles promoted the cleavage PARP-1, caspase-3 and caspase-9, increased the expression levels of Bax, Bad, PUMA, and reduced the expression level of Bcl-2. Moreover, in the spleen of heterotopic tumor model BALB/c mice, ERN, LP-ERN and Tf-LP-ERN nanoparticles increased the expression levels of Nrf2, HO-1, SOD-1 and SOD-2, but reduced the expression levels of P-IKKα+β and P-NF-κB, with Tf-LP-ERN nanoparticles being most effective in this regard. Tf-LP-ERN nanoparticles also regulated the expression levels of TNF-α, IL-10 and CCL11 in serum.ConclusionTf-LP-ERN nanoparticles exhibited excellent anti-liver cancer activity in vivo and in vitro by inducing cellular apoptosis, exhibiting immunoregulatory actions, and targeting tumor tissues, and did so more effectively than free ERN and LP-ERN nanoparticles. These results suggest that the clinical utility of a Tf-conjugated LP ERN-delivery system for the treatment of liver cancer warrants exploration.
first_indexed 2024-12-17T12:58:21Z
format Article
id doaj.art-c6d43fbab8be44a68b7c4297f0341ffe
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-17T12:58:21Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-c6d43fbab8be44a68b7c4297f0341ffe2022-12-21T21:47:26ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-08-011110.3389/fonc.2021.727605727605Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative StressAnhui Yang0Zhen Sun1Rui Liu2Xin Liu3Yue Zhang4Yulin Zhou5Ye Qiu6Xinrui Zhang7Xinrui Zhang8School of Life Sciences, Jilin University, Changchun, ChinaSchool of Life Sciences, Jilin University, Changchun, ChinaSchool of Life Sciences, Jilin University, Changchun, ChinaSchool of Life Sciences, Jilin University, Changchun, ChinaSchool of Life Sciences, Jilin University, Changchun, ChinaSchool of Life Sciences, Jilin University, Changchun, ChinaDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, ChinaSchool of Life Sciences, Jilin University, Changchun, ChinaDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, ChinaBackgroundLiver cancer is one of the most malignant human cancers, with few treatments and a poor prognosis. Erianin (ERN) is a natural compound with multiple pharmacological activities that has been reported to have numerous excellent effects against liver cancer in experimental systems. However, its application in vivo has been limited due to its poor aqueous solubility and numerous off-target effects. This study aimed to improve the therapeutic efficacy of ERN by developing novel ERN-loaded tumor-targeting nanoparticles.ResultsIn this study, ERN was loaded into liposomes by ethanol injection (LP-ERN), and the resulting LP-ERN nanoparticles were treated with transferrin to form Tf-LP-ERN to improve the solubility and enhance the tumor-targeting of ERN. LP-ERN and Tf-LP-ERN nanoparticles had smooth surfaces and a uniform particle size, with particle diameters of 62.60 nm and 88.63 nm, respectively. In HepG2 and SMMC-7721 cells, Tf-LP-ERN induced apoptosis, decreased mitochondrial membrane potentials and increased ERN uptake more effectively than free ERN and LP-ERN. In xenotransplanted mice, Tf-LP-ERN inhibited tumor growth, but had a minimal effect on body weight and organ morphology. In addition, Tf-LP-ERN nanoparticles targeted tumors more effectively than free ERN and LP-ERN nanoparticles, and in tumor tissues Tf-LP-ERN nanoparticles promoted the cleavage PARP-1, caspase-3 and caspase-9, increased the expression levels of Bax, Bad, PUMA, and reduced the expression level of Bcl-2. Moreover, in the spleen of heterotopic tumor model BALB/c mice, ERN, LP-ERN and Tf-LP-ERN nanoparticles increased the expression levels of Nrf2, HO-1, SOD-1 and SOD-2, but reduced the expression levels of P-IKKα+β and P-NF-κB, with Tf-LP-ERN nanoparticles being most effective in this regard. Tf-LP-ERN nanoparticles also regulated the expression levels of TNF-α, IL-10 and CCL11 in serum.ConclusionTf-LP-ERN nanoparticles exhibited excellent anti-liver cancer activity in vivo and in vitro by inducing cellular apoptosis, exhibiting immunoregulatory actions, and targeting tumor tissues, and did so more effectively than free ERN and LP-ERN nanoparticles. These results suggest that the clinical utility of a Tf-conjugated LP ERN-delivery system for the treatment of liver cancer warrants exploration.https://www.frontiersin.org/articles/10.3389/fonc.2021.727605/fullerianintransferrin-conjugated liposomesliver cancerapoptosismitochondrialoxidative stress
spellingShingle Anhui Yang
Zhen Sun
Rui Liu
Xin Liu
Yue Zhang
Yulin Zhou
Ye Qiu
Xinrui Zhang
Xinrui Zhang
Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress
Frontiers in Oncology
erianin
transferrin-conjugated liposomes
liver cancer
apoptosis
mitochondrial
oxidative stress
title Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress
title_full Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress
title_fullStr Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress
title_full_unstemmed Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress
title_short Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress
title_sort transferrin conjugated erianin loaded liposomes suppress the growth of liver cancer by modulating oxidative stress
topic erianin
transferrin-conjugated liposomes
liver cancer
apoptosis
mitochondrial
oxidative stress
url https://www.frontiersin.org/articles/10.3389/fonc.2021.727605/full
work_keys_str_mv AT anhuiyang transferrinconjugatederianinloadedliposomessuppressthegrowthoflivercancerbymodulatingoxidativestress
AT zhensun transferrinconjugatederianinloadedliposomessuppressthegrowthoflivercancerbymodulatingoxidativestress
AT ruiliu transferrinconjugatederianinloadedliposomessuppressthegrowthoflivercancerbymodulatingoxidativestress
AT xinliu transferrinconjugatederianinloadedliposomessuppressthegrowthoflivercancerbymodulatingoxidativestress
AT yuezhang transferrinconjugatederianinloadedliposomessuppressthegrowthoflivercancerbymodulatingoxidativestress
AT yulinzhou transferrinconjugatederianinloadedliposomessuppressthegrowthoflivercancerbymodulatingoxidativestress
AT yeqiu transferrinconjugatederianinloadedliposomessuppressthegrowthoflivercancerbymodulatingoxidativestress
AT xinruizhang transferrinconjugatederianinloadedliposomessuppressthegrowthoflivercancerbymodulatingoxidativestress
AT xinruizhang transferrinconjugatederianinloadedliposomessuppressthegrowthoflivercancerbymodulatingoxidativestress